SELLAS Life Sciences Group, Inc. (SLS)
4.15
+0.11
(+2.72%)
USD |
NASDAQ |
Feb 20, 16:00
4.25
+0.10
(+2.41%)
After-Hours: 20:00
SELLAS Life Sciences Group SG&A Expense (Quarterly) : 2.867M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| GT Biopharma, Inc. | 2.748M |
| Amicus Therapeutics, Inc. | 117.08M |
| Geron Corp. | 39.00M |
| Vanda Pharmaceuticals, Inc. | 62.98M |
| ADMA Biologics, Inc. | 23.05M |